ALDH2 and non-small cell lung carcinoma: Importantly, in order to confirm the relationship between ALDH2 and PTX sensitivity in NSCLC patients, we determined ALDH2 expression levels in tissue specimens from 46 NSCLC patients with PTX-based treatment.